SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹10 Cr | ₹10 Cr | ₹8.57 Cr | ₹7.09 Cr | ₹6.83 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SAKAR HEALTHCARE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹10 Cr |
| Mar2024 | ₹10 Cr |
| Mar2023 | ₹8.57 Cr |
| Mar2022 | ₹7.09 Cr |
| Mar2021 | ₹6.83 Cr |
How is Deferred Tax Assets / Liabilities of SAKAR HEALTHCARE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹10 Cr | 3.18 | |
| Mar2024 | ₹10 Cr | 16.94 | |
| Mar2023 | ₹8.57 Cr | 20.87 | |
| Mar2022 | ₹7.09 Cr | 3.88 | |
| Mar2021 | ₹6.83 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,155.7 Cr | 12.7% | 37.1% | 128.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 12.7% |
37.1% |
128.4% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses